Furthermore, we compared the pathway differences of RGS5+fibroblasts among different groups, and the results revealed the enrichment of pathways related to epithelial-mesenchymal transition and extracellular matrix receptor responses in obese CRC samples (Fig. 4E). This evidence concerns the gene RGS5 and colorectal carcinoma.